A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1 … ad-hoc working group of ERBP:, D Fliser, M Laville, A Covic, D Fouque, ... Nephrology Dialysis Transplantation 27 (12), 4263-4272, 2012 | 644 | 2012 |
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine A Mathian, M Mahevas, J Rohmer, M Roumier, F Cohen-Aubart, ... Annals of the rheumatic diseases 79 (6), 837-839, 2020 | 271 | 2020 |
Paraneoplastic glomerular diseases and malignancies J Bacchetta, L Juillard, P Cochat, JP Droz Critical reviews in oncology/hematology 70 (1), 39-58, 2009 | 261 | 2009 |
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 250 | 2021 |
Blood oxygen level–dependent measurement of acute intra-renal ischemia L Juillard, LO Lerman, DG Kruger, JA Haas, BC Rucker, JA Polzin, ... Kidney international 65 (3), 944-950, 2004 | 187 | 2004 |
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell‐defective apoptosis and hyperproliferation A Belot, PR Kasher, EW Trotter, AP Foray, AL Debaud, GI Rice, ... Arthritis & Rheumatism 65 (8), 2161-2171, 2013 | 179 | 2013 |
Classification of uremic toxins and their role in kidney failure MH Rosner, T Reis, F Husain-Syed, R Vanholder, C Hutchison, ... Clinical Journal of the American Society of Nephrology 16 (12), 1918-1928, 2021 | 135 | 2021 |
Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) C Ichai, C Vinsonneau, B Souweine, F Armando, E Canet, C Clec’h, ... Annals of intensive care 6, 1-20, 2016 | 124 | 2016 |
Early impairment of trabecular microarchitecture assessed with HR‐pQCT in patients with stage II‐IV chronic kidney disease J Bacchetta, S Boutroy, N Vilayphiou, L Juillard, F Guebre‐Egziabher, ... Journal of Bone and Mineral Research 25 (4), 849-857, 2010 | 118 | 2010 |
Accuracy of GFR estimation in obese patients S Lemoine, F Guebre-Egziabher, F Sens, MS Nguyen-Tu, L Juillard, ... Clinical Journal of the American Society of Nephrology 9 (4), 720-727, 2014 | 111 | 2014 |
Modified lipids and lipoproteins in chronic kidney disease: a new class of uremic toxins N Florens, C Calzada, E Lyasko, L Juillard, CO Soulage Toxins 8 (12), 376, 2016 | 109 | 2016 |
Elevation of trimethylamine-N-oxide in chronic kidney disease: contribution of decreased glomerular filtration rate CC Pelletier, M Croyal, L Ene, A Aguesse, S Billon-Crossouard, M Krempf, ... Toxins 11 (11), 635, 2019 | 107 | 2019 |
Contrast-induced acute kidney injury: how should at-risk patients be identified and managed? M Laville, L Juillard JN journal of nephrology 23 (4), 387, 2010 | 93 | 2010 |
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors Annals of the Rheumatic Diseases 80 (4), 527-538, 2021 | 86 | 2021 |
Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis M Laville, M Dorval, JF Ros, R Fay, J Cridlig, JL Nortier, L Juillard, ... Kidney international 86 (6), 1260-1267, 2014 | 86 | 2014 |
The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease J Bacchetta, S Boutroy, F Guebre-Egziabher, L Juillard, J Drai, S Pelletier, ... Nephrology Dialysis Transplantation 24 (10), 3120-3125, 2009 | 85 | 2009 |
Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible? J Dumortier, O Guillaud, MC Gagnieu, B Janbon, L Juillard, E Morelon, ... Journal of Clinical Virology 56 (2), 146-149, 2013 | 84 | 2013 |
Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study N Janus, V Launay-Vacher, A Thyss, H Boulanger, O Moranne, MS Islam, ... Annals of oncology 24 (2), 501-507, 2013 | 83 | 2013 |
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD‐REIN cohort SM Laville, M Metzger, B Stengel, C Jacquelinet, C Combe, D Fouque, ... British Journal of Clinical Pharmacology 84 (12), 2811-2823, 2018 | 80 | 2018 |
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis M Espi, X Charmetant, T Barba, C Mathieu, C Pelletier, L Koppe, ... Kidney international 101 (2), 390-402, 2022 | 72 | 2022 |